Skip to content

Intra-operative Neuromodulation of the Pelvic Plexus

Intra-operative Neuromodulation of the Pelvic Plexus

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03425240
Enrollment
20
Registered
2018-02-07
Start date
2014-09-10
Completion date
2018-12-31
Last updated
2018-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erectile Dysfunction, Prostate Cancer

Keywords

Erectile Dysfunction, Prostate Cancer, Neuromodulation

Brief summary

The purpose of this study is to evaluate the feasibility of electrical stimulation of nerves responsible for erectile function to evoke penile erection after surgery to remove the prostate (prostatectomy).

Detailed description

Prostate cancer is the main cancer in men. However, the survival rate for clinically localized prostate cancer is prominent mainly due to radical prostatectomy (RP), the gold standard treatment for non-metastatic cancers. Unfortunately, despite providing optimal cancer control, RP often lead to neuropraxia and persistent erectile dysfunction in approximately 80% of men 1 year after prostatectomy. Various erectile rehabilitation strategies have not been able to prove a beneficial action yet. However, electrical stimulation has been demonstrated to favour neuroregeneration and the functional recovery of neuromuscular systems and has been shown to induce and maintain penile erection in animals and humans. Therefore, electrical stimulation of the pelvic plexus nerves during radical prostatectomy is being investigated for its potential development into a treatment aimed at improving recovery of erectile function after prostatectomy. The primary objective of this study is to explore the feasibility of using a neurostimulation device post radical prostatectomy as a method for neurogenic erectile dysfunction treatment. During standard open radical prostatectomy, the pelvic plexus nerves will be electrically stimulated intraoperatively and the modification of penile circumference will be recorded. The secondary objective is to assess proper placement of the stimulation electrodes and stimulation parameters needed to achieve maximal change in penile circumference.

Interventions

Acute placement of electrodes on the pelvic plexus to apply electrostimulation during open radical prostatectomy.

Sponsors

Laikο General Hospital, Athens
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
40 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Scheduled for open radical prostatectomy procedure under total anesthesia. * Age 40 to 75 years old. * Able to read and understand patient information materials and willing to sign a written informed consent.

Exclusion criteria

* Have been diagnosed with severe vasculogenic erectile dysfunction. * Have a prior history of pelvic surgery, trauma or irradiation therapy. * Have a penile prosthesis. * Have been diagnosed with neurologic diseases that may negatively impact erectile functions. * Currently having an active implantable device (such as a pacemaker). * Posses any other characteristics that, per the investigator's judgment, may increase the risk or impair data collection for the procedure/study. * Inability to provide a fully informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Penile circumference increase in millimeters.5 minutesChange in penile circumference \[mm\] in response to electrical stimulation of the pelvic plexus nerves measured by a penile plethysmograph.

Secondary

MeasureTime frameDescription
Anatomic location of stimulation site5 to 15 minutesThe anatomic location of the stimulation site on the pelvic floor (determined by the surgeon).
Stimulation threshold in volts5 to 15 minutesAmplitude in volts of the electrical stimulation pulses to induce penile response.

Countries

Greece

Contacts

Primary ContactSpyridon Skoufias, MD
spyskouf@hotmail.comspyskouf@hotmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026